APA

Beer T. M., Goldman B., Synold T. W., Ryan C. W., Vasist L. S., Van Veldhuizen P. J., Dakhil S. R., Lara P. N., Drelichman A., Hussain M. H. A. & Crawford E. D. (20081216). Southwest Oncology Group phase II study of ispinesib in androgen-independent prostate cancer previously treated with taxanes. : Clinical genitourinary cancer.

Chicago

Beer Tomasz M, Goldman Bryan, Synold Timothy W, Ryan Christopher W, Vasist Lakshmi S, Van Veldhuizen Peter J, Dakhil Shaker R, Lara Primo N, Drelichman Anibal, Hussain Maha H A and Crawford E David. 20081216. Southwest Oncology Group phase II study of ispinesib in androgen-independent prostate cancer previously treated with taxanes. : Clinical genitourinary cancer.

Harvard

Beer T. M., Goldman B., Synold T. W., Ryan C. W., Vasist L. S., Van Veldhuizen P. J., Dakhil S. R., Lara P. N., Drelichman A., Hussain M. H. A. and Crawford E. D. (20081216). Southwest Oncology Group phase II study of ispinesib in androgen-independent prostate cancer previously treated with taxanes. : Clinical genitourinary cancer.

MLA

Beer Tomasz M, Goldman Bryan, Synold Timothy W, Ryan Christopher W, Vasist Lakshmi S, Van Veldhuizen Peter J, Dakhil Shaker R, Lara Primo N, Drelichman Anibal, Hussain Maha H A and Crawford E David. Southwest Oncology Group phase II study of ispinesib in androgen-independent prostate cancer previously treated with taxanes. : Clinical genitourinary cancer. 20081216.